Medical researchers at the University of Alberta studied the records of nearly 1000 patients who were admitted to hospital with pneumonia and noted those who were obese were more apt to survive compared to those who were of normal weight.
For their research study, the team examined the records of 907 patients with pneumonia who were admitted to six Edmonton hospitals and also had their body mass index recorded. Two-thirds of the patients had severe pneumonia and 79 died in hospital. Of those who died, 12 were under weight, 36 were normal weight, 21 were overweight and 10 were obese. Compared to those who were normal weight, obese patients had lower in-hospital mortality rates due to pneumonia, says the study, which was led by Faculty of Medicine & Dentistry researcher Sharry Kahlon, who works in the Department of Medicine and is a resident in internal medicine. Mortality was 10 per cent for those who were normal weight and 4 per cent for those who were obese. This translates into a 54 per cent reduction in mortality associated with being obese. The results of the study were recently published in the peer-reviewed journal Clinical Microbiology and Infection.
Kahlon says the research supports the 'obesity paradox' – that in some circumstances being obese may be better for your health, even though obesity is associated with an increased risk of diabetes, hypertension, death and catching infections like pneumonia.
"The thinking usually is obesity equals bad and this research demonstrated something different. It shows that perhaps we're not looking at obesity in the right way. Is all fat bad? Is all fat equal? For acute illnesses, maybe we're not looking at the right indicators for body mass index and obesity."
Kahlon says previous studies have demonstrated the 'obesity paradox' in relation to chronic diseases, but this is one of a handful of studies to demonstrate the link with acute medical conditions. In the study, she notes obese patients may have had better survival rates because they had more nutritional reserves.
"It might be a misregulation of the inflammatory system that allows these individuals to do better," she says. "These mechanisms still need to be better studied."
She noted physicians may need to adjust prescriptions or care for obese patients hospitalized with pneumonia – to better meet their medical needs.
Former Faculty of Medicine & Dentistry Dean Tom Marrie was part of the research team and found the patients to take part in the study.
University of Alberta Faculty of Medicine & Dentistry: http://www.med.ualberta.ca
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Surgeons in Australia say they have performed the first heart transplant using a "dead heart".
Ebola underlines the urgent need for a new way of responding to global epidemics, say Harvey Rubin and Nicholas Saidel
As researchers from Africa to China to America race to develop vaccines and treatments to fight Ebola, health experts are grappling with the economics of a disease that until this year had been off the drug industry's radar.
Is California's severe drought hurting the nutrient content of fruit? No, preliminary data on pomegranates suggest. The fruit may be smaller, but packed with more antioxidants, tests show.
The Food and Drug Administration has issued warning letters to companies marketing products claimed to be cures for Ebola. One firm says it will drop such claims — but it's still selling the product.
Parents of baby with fatal mitochondrial disease say techniques being considered by select committee could prevent them having another seriously ill child
Ultrasound has been used to open the brain's protective sheath in people with aggressive brain tumours – to deliver chemo drugs directly to cancer cells
The World Health Organization says two vaccine candidates now undergoing small-scale tests of dosage and safety in people might be ready for broader deployment in Africa by early 2015.
Just because the Food and Drug Administration recalls a supplement because it contains dangerous substances, doesn't mean the product disappears from the market.
9 million new cases and 1.5 million deaths in 2013